Tag: Aspirin

Risk increased for recurrent MI, ischemic stroke, or death with suboptimal adherence through eight years after MI

Estimates of use increased from 16.6 percent in low-income countries to 65.0 percent in high-income countries

But significant increase in intracranial bleeding seen for those receiving aspirin versus placebo

Reduced risk seen for composite of cardiovascular death, myocardial infarction, and stroke

Risk for anemia incidence and decline in ferritin greater for seniors receiving low-dose aspirin

Findings seen in patients with ischemic stroke without occlusion of large or medium-sized vessels, at least one moderately to severely weak limb

Study shows that polygenic score does not modify the 13 percent reduction in ovarian cancer risk seen with aspirin

Aspirin discontinuation at 24 to 28 weeks gestation noninferior to continuation until 36 weeks of gestation

No significant difference seen in incidence of death, deep vein thrombosis, pulmonary embolism, bleeding complications

Protection against aspirin-associated peptic ulcer bleeding in older adults lost after the first 2.5 years